[Parvovirus B19 infections in adults].
Infection de l’adulte à Parvovirus.
Antiphospholipid syndrome
Lupus
Parvovirus B19
Polyarthrite rhumatoïde
Rheumatoid arthritis
SAPL
Systemic lupus erythematosus
Vascularites
Vasculitis
Journal
La Revue de medecine interne
ISSN: 1768-3122
Titre abrégé: Rev Med Interne
Pays: France
ID NLM: 8101383
Informations de publication
Date de publication:
Dec 2022
Dec 2022
Historique:
received:
30
06
2022
revised:
29
07
2022
accepted:
21
08
2022
pubmed:
11
9
2022
medline:
7
12
2022
entrez:
10
9
2022
Statut:
ppublish
Résumé
Acute Parvovirus B19 (PVB19) infection is responsible for erythema infectiosum in children and non-specific polyarthralgias in immunocompetent adults associated with skin lesions and rarer manifestations (hepatic, neurological, cardiac or nephrological). In immunocompromised patients, cytopenias are more frequent and in some cases, viremia persists and is responsible for PVB19 chronic infection. PVB19 is responsible for pure red cell aplasia during chronic hemolytic diseases. Acute PVB19 infection is a differential diagnosis of some autoimmune diseases and has been suspected to be a trigger for some autoimmune diseases because of its ability to promote the emergence of autoimmune markers. Mechanisms of molecular mimicry, induction of apoptosis and activation of enzymes have been demonstrated, explaining in part the production of autoantibodies during infection. However, the demonstration of a causal relationship in the triggering of autoimmune disease remains to be done. This review provides a synthesis of the PVB19 infection clinical data in adults with a particular focus on these links with autoimmunity.
Identifiants
pubmed: 36088203
pii: S0248-8663(22)00609-9
doi: 10.1016/j.revmed.2022.08.005
pii:
doi:
Substances chimiques
Autoantibodies
0
Types de publication
English Abstract
Journal Article
Review
Langues
fre
Sous-ensembles de citation
IM
Pagination
713-726Informations de copyright
Copyright © 2022 Société Nationale Française de Médecine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.